03.01.05
The results of a clinical trial investigating the effects of Jarrow Formulas’ BioSil product on sun damaged or prematurely aging skin were presented at the International Symposium of the International Society for Bioengineering and the Skin, which was held in Orlando, FL, late last year. Scientists at the Free University of Brussels conducted a 20-week double-blind, placebo controlled study using 50 women ages 40 to 65, who had clear signs of sun damaged or prematurely aging skin. Half received 10 mg of BioSil, while the other half received a placebo. The BioSil group experienced a significant improvement over the placebo group including, shallower micro wrinkles up to 30% better than placebo; improved skin elasticity 55% better than placebo; and a significant reduction of brittleness in hair and nails. BioSil (U.S. patent 5,922,360 and other patents pending) is a silicon supplement, which contains a choline-stabilized and concentrated form of orthosilicic acid, ch-OSA.